TERT: Telomerase reverse transcriptase
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes.
- Drugs that act on it: 2
- With a US drug page: 2
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Imetelstat | Approved | Telomerase reverse transcriptase inhibitor | Inhibitor | — |
| Imetelstat sodium | Approved | Telomerase reverse transcriptase inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Dyskeratosis congenita, autosomal dominant 2
- 0.86
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
- 0.81
- Dyskeratosis congenita
- 0.80
- Autosomal recessive dyskeratosis congenita 4
- 0.71
- Aplastic anemia
- 0.70
- Melanoma, cutaneous malignant, susceptibility to, 9
- 0.65
- Prostate carcinoma
- 0.64
Drugs and mechanisms are from ChEMBL CHEMBL2916 (CC BY-SA 3.0). Gene name, function (UniProt O14746, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets